Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma - Concepedia

Concepedia

Publication | Closed Access

Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma

171

Citations

28

References

2006

Year

Bruce E. Loveland, Anne Zhao, Shane White, Hui Gan, Kate Hamilton, Pei‐Xiang Xing, Geoffrey A. Pietersz, Vasso Apostolopoulos, Hilary Vaughan, Vaios Karanikas,

Clinical Cancer Research

Abstract

Immunization produced T-cell responses in all patients with evidence of tumor stabilization in 2 of the 10 advanced cancer patients treated. These data support further clinical evaluation of this dendritic cell-MFP immunotherapy.

References

	Year	Citations

Page 1